Related Experiment Video
Updated: Apr 5, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
Activating Mutations in PIK3CA Lead to Widespread Modulation of the Tyrosine Phosphoproteome
Muhammad Saddiq Zahari1, Xinyan Wu1, Brian G Blair2
1McKusick-Nathans Institute of Genetic Medicine and Department of Biological Chemistry, Johns Hopkins University School of Medicine, 733 North Broadway Street, Baltimore, Maryland 21205, United States.
Abstract:
The human oncogene PIK3CA is frequently mutated in human cancers. Two hotspot mutations in PIK3CA, E545K and H1047R, have been shown to regulate widespread signaling events downstream of AKT, leading to increased cell proliferation, growth, survival, and motility. We used quantitative mass spectrometry to profile the global phosphotyrosine proteome of isogenic knock-in cell lines containing these activating mutations, where we identified 824 unique phosphopeptides. Although it is well understood that these mutations result in hyperactivation of the serine/threonine kinase AKT, we found a surprisingly widespread modulation of tyrosine phosphorylation levels of proteins in the mutant cells. In the tyrosine kinome alone, 29 tyrosine kinases were altered in their phosphorylation status. Many of the regulated phosphosites that we identified were located in the kinase domain or the canonical activation sites, indicating that these kinases and their downstream signaling pathways were activated. Our study demonstrates that there is frequent and unexpected cross-talk that occurs between tyrosine signaling pathways and serine/threonine signaling pathways activated by the canonical PI3K-AKT axis.
Insights
Mutations in the PIK3CA gene drive cancer by activating AKT signaling. This study reveals PIK3CA mutations also unexpectedly alter tyrosine kinase activity, uncovering cross-talk between signaling pathways.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The PIK3CA gene is a human oncogene frequently mutated in various cancers.
- Specific hotspot mutations (E545K, H1047R) activate the AKT signaling pathway, promoting cancer cell proliferation, survival, and motility.
Purpose of the Study:
- To investigate the global phosphotyrosine proteome changes in cells with PIK3CA hotspot mutations.
- To identify novel signaling cross-talk between the PI3K-AKT pathway and tyrosine kinases.
Main Methods:
- Quantitative mass spectrometry was employed to profile the phosphotyrosine proteome.
- Isogenic knock-in cell lines harboring PIK3CA E545K and H1047R mutations were utilized.
Main Results:
- Identification of 824 unique phosphopeptides, indicating widespread phosphoproteome alterations.
- Significant modulation of phosphorylation status in 29 tyrosine kinases was observed.
- Many regulated phosphosites were located in kinase domains or activation sites, suggesting kinase activation.
Conclusions:
- PIK3CA mutations induce extensive changes in tyrosine phosphorylation beyond AKT hyperactivation.
- Unexpected cross-talk exists between tyrosine kinase signaling and the canonical PI3K-AKT pathway in cancer.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
MAPK Signaling Cascades

